Skip to main content

West Virginia Medical Marijuana Sales Start Delayed Until 2021 Or 2022

Two steps forward, one back

It’s interesting to contrast differing banking news that hit this week in West Virginia and Florida.

West Virginia Gov. Jim Justice signed a medical marijuana banking bill that will allow financial institutions in the state to bid on providing banking services related to the state’s MMJ program.

But SunTrust Bank in Tallahassee, Florida, revealed it was closing the account of the Medical Marijuana Business Association of Florida on April 18.

MJBizDaily takeaway: Any moves to improve cannabis banking access are welcome, but short of federal action (click here for more on that topic), banks will remain leery of taking marijuana business customers, noted Rachel Gillette, head of the cannabis practice at the Greenspoon Marder law firm.

SunTrust’s move against the Florida MMJ association “highlights the urgency” of passing a federal banking bill, Gillette said.

In a blow to businesses hoping to quickly enter the West Virginia medical marijuana market, it could take up to three years before the new cannabis program is launched, a state official confirmed to Marijuana Business Daily.

Allison Adler, director of communications for the West Virginia Department of Health, wrote in an email to MJBizDaily  that the “primary cause” behind the projected two-to-three year delay is concern over the ability of MMJ companies to secure banking services. The banking issue was addressed in recent legislation.

The state treasurer, Adler noted, recently issued a request for proposals from financial institutions interested in providing banking services to the industry. However, the proposals will “require time to evaluate and implement.”

Adler continued that “it is important to note that after a solution to the current banking issue is found, it will take time for multiple stages of the medical cannabis permitting process to be implemented.”

The whole process, she added, also requires program staffing and development, rules implementation, and registration of medical providers and patients.

Advance work already undertaken by the state should shorten this timeline, according to Adler. Still, her office  estimates it will take two to three years after a fix to the banking issue before dispensaries will open.

MJBizDaily previously projected sales would start sometime in 2020.

When West Virginia’s program is up and running, it will have these business elements, according to legislation passed in May:

  • Up to 10 growers. Each grower may have up to two locations per permit.
  • Up to 10 processors.
  • Up to 100 dispensaries.

An individual or business is permitted to hold a grower, processor and dispensary permit, but one individual can’t hold more than 10 dispensary permits.

Before a permit is issued, the applicant must get written approval from the board of health in the county where the business is going to be located.

Original Article Source: https://mjbizdaily.com/west-virginia-medical-marijuana-sales-start-delayed-until-2021-or-2022/

Comments

Popular posts from this blog

Mormon Church Faces Potential Lawsuit Over Medical Marijuana Opposition

Political committees concerned with marijuana law reform in four states have waged an information war over the past year, first to qualify cannabis initiatives for the ballot, and then to support or oppose those measures in the lead-up to last week’s midterm elections. In total, over  $12.9 million in cash and in-kind services was spent attempting to convince voters about these marijuana ballot measures. Now that voters have had their say, Marijuana Moment decided to calculate how much each “yes” and “no” vote cost the committees on either side of the debate. Our calculations are based on dollars raised and disclosed before the election, since final totals of actual expenditures won’t be available until December or January reports required in the states that voted on cannabis. Michigan In Michigan, where voters approved marijuana legalization , our calculations show that the two anti-legalization committees spent about $1.28 per “no” vote, as they raised $2.37 million for ...

Could CBD Lead To The Development Of Safer Antipsychotic Medications?

Antipsychotic medications are important for managing a number of different psychiatric ailments, including bipolar disorders, schizophrenia, and even dementia. These drugs can greatly improve the manageability of symptoms that often distort one’s experience of reality. They can also create major mood disruptions and lead to a number of behavioral and emotional difficulties. Antipsychotic and anti-psychosis medications can be life-changing for people with such disorders, enabling them to live more normal and manageable lives without their symptoms taking over. These drugs work by regulating neurotransmitters in the brain so that naturally occurring imbalances and dysfunctions no longer disrupt mental and emotional processes. Often, reaching this outcome is much easier said than done; it can take a lot of time to find courses and combinations of treatments that work. It’s sometimes necessary to make adjustments to find the right balance for the individual and it’s not unusual for outc...

NY Dem Chair Warns Against Passing Voter-Supported Marijuana Legalization Bill

The head of New York’s Democratic Party said on Thursday that if the state Senate votes on a marijuana legalization bill, his party’s lawmakers run the risk of alienating voters and losing reelection next year. Jay Jacobs, the state party chairman, claimed that several “far progressive” measures, including cannabis legalization, lack popularity in certain areas across the state such as Long Island and upstate New York. He cautioned lawmakers against putting the issue to a vote, arguing that voters would “throw us out of office.” “It could be the straw that breaks the camel’s back,” he told Newsday. Polling doesn’t support that conclusion, though. According to a March 2019 survey from Quinnipiac, 65 percent of New Yorkers are in favor of allowing adults to legally possess cannabis for personal use. That includes 63 percent of respondents in upstate New York and 65 percent of those living in the suburbs. Sixty-six percent of independents statewide also back ending marijuana prohibit...